African-Americans with a difficult-to-treat strain of hepatitis C experience a “significantly lower response rate” than non-Hispanic whites to the drug combination peginterferon alfa-2b and ribavirin, according to research performed at Duke University Medical Center.

The study, led by Andrew Muir, an assistant professor of medicine at Duke University Medical Center, showed that 19 percent of blacks infected with the HCV genotype 1 strain responded to the drug combination compared with 52 percent of non-Hispanic whites with the same disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Jay Shendure and his colleagues have developed a new method to more comprehensively identify human cell types, the NY Times reports.

Researchers in the UK and Japan have shown that infertility in mice with three sex chromosomes can be overcome, according to the Guardian.

China is embracing preimplantation genetic diagnosis, Nature News reports. 

In PLOS this week: host genetic factors associated with cervical neoplasia progression, population patterns for an ancient flowering rainforest plant, and more.